Interleukin Genetics (ILI) Receives Approval to Sell PST Genetic Test in New York
Tweet Send to a Friend
Interleukin Genetics, Inc. (AMEX: ILI) announced today it has received approval by the State of New York's Department of Health ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
